News

Devdiscourse13d
How AI is shaping the next generation of nanobody drugs
The timeline of nanobody development reflects a steady series of innovations. In 2001, the term "nanobody" was introduced by ...
PharmiWeb16d
AbTherx, Single Cell Technology, and Vaccinex Announce Collaboration to Tackle Challenging Antibody Drug Targets
AbTherx and Single Cell Technology incorporate ActivMAb® Technology into Atlas™ Mouse and AbTheneum™ antibody discovery platforms MOUNTAIN VIEW, CA / ACCESS Newswire / May 13, 2025 / AbTherx, ...
GEN - Genetic Engineering and Biotechnology News14h
Absci Advances Lead AI-Designed Candidate for IBD into the Clinic
Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...
Fintel on MSN14h
Wedbush Downgrades iTeos Therapeutics (ITOS)
Fintel reports that on May 28, 2025, Wedbush downgraded their outlook for iTeos Therapeutics (NasdaqGM:ITOS) from Outperform ...
Fintel on MSN14h
Wells Fargo Downgrades iTeos Therapeutics (ITOS)
Fintel reports that on May 28, 2025, Wells Fargo downgraded their outlook for iTeos Therapeutics (NasdaqGM:ITOS) from ...
Applied Clinical Trials Online14d
iTeos and GSK Halt TIGIT Antibody Belrestotug Development After Phase II Trials Miss Efficacy Marks in NSCLC and HNSCC
Decision follows underwhelming Phase II results from GALAXIES Lung-201 and H&N-202 trials, prompting iTeos and GSK to end ...
Carvykti Market Research, Epidemiology, Pipeline Analysis, Market Insights & Forecasts
Major players operating in the carvykti market are Johnson & Johnson Services Inc., Legend Biotech, and Novartis AG. North America was the largest region in the carvykti market in 2024. Asia-Pacific ...